Przegląd Dermatologiczny

Abstract

4/2017 vol. 104
Meta-analysis

Treatment of atopic dermatitis with cyclosporin A: a case report

Dermatol Rev/Przegl Dermatol 2017, 104, 432-438
Online publish date: 2017/09/15
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Introduction. Despite the progress that has been made in the therapy of atopic dermatitis in recent years, cyclosporin A remains the first-line treatment of severe forms of the disease.

Objective. To present a case of effective cyclosporin A therapy of severe atopic dermatitis with features of secondary bacterial infection.

Case report. A 22-year-old man was admitted to hospital with extensive erythematous-desquamative skin lesions. The lesions were accompanied by intense itching. Based on the patient’s medical history, physical examination, laboratory test results and histological examination of a skin biopsy, atopic dermatitis with bacterial superinfection was diagnosed. Treatment with cyclosporin A in combination with antibiotics was initiated, resulting in significant clinical improvement within a few days after the initiation of therapy.

Conclusions. Our case confirms that cyclosporin A is a fast-acting and highly effective therapeutic agent in atopic dermatitis, and the risk of adverse reactions, if the drug is used properly, is low.
Share
without publication fees
without publication fees